Cargando…
Protocol to screen for Sorafenib resistance regulators using pooled lentiviral shRNA library and a Sorafenib-resistant hepatocellular carcinoma cell model
Approaches to study therapy resistance in HCC (hepatocellular carcinoma) are limited, especially when using HCC models in vitro. Here, we present a protocol to establish an in vitro Sorafenib-resistant human HCC cell model and conduct an shRNA-mediated synthetic lethal screen in established Sorafeni...
Autores principales: | Gao, Ruize, Tang, Fengyuan, Christofori, Gerhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165445/ https://www.ncbi.nlm.nih.gov/pubmed/37126443 http://dx.doi.org/10.1016/j.xpro.2023.102273 |
Ejemplares similares
-
Generation of a pooled shRNA library for functional genomics screens
por: Papadopoulos, Dimitrios, et al.
Publicado: (2022) -
YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis
por: Gao, Ruize, et al.
Publicado: (2021) -
Construction of shRNA lentiviral vector
por: Song, Hong, et al.
Publicado: (2010) -
USP29-mediated HIF1α stabilization is associated with Sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysis
por: Gao, Ruize, et al.
Publicado: (2021) -
A descriptive guide for absolute quantification of produced shRNA pseudotyped lentiviral particles by real-time PCR
por: Mournetas, Virginie, et al.
Publicado: (2016)